Market Opportunity

With the growing burden of digestive cancers, the market for AI-powered endoscopy and cancer detection solutions is rapidly expanding.

Global Market Size for Gastrointestinal Diagnostics

• Total GI diagnostic & treatment market: $187 billion

Breakdown by specific cancers:

• Stomach cancer: $135 billion

• Colorectal cancer: $27 billion

• Esophageal and other GI cancers: $26 billion

---

Endoscopic Imaging Market

• Global endoscopic screening market (U.S., China, Japan, Europe, Korea): $108 billion

• U.S. endoscopic screening market: $63 billion

---

AI-Powered Diagnostic Market

• U.S. AI-assisted endoscopic image interpretation market: $6.3 billion (Assuming a 10% AI adoption rate in the U.S. endoscopy market)

• Korean AI-assisted endoscopic image interpretation market: $72 million (Assuming a 10% AI adoption rate in Korea)

• Global AI-driven GI diagnostics market: Projected multi-billion-dollar opportunity

Apex AI’s Vision

Apex AI aims to redefine early cancer detection by leveraging AI to analyze endoscopic images, predict cancer risks, and track disease progression in real time. Our mission is to increase survival rates and optimize clinical workflows by providing AI-assisted precision diagnostics for gastroenterologists worldwide.

With the rapid growth of AI adoption in healthcare, Apex AI is positioned to be a leader in the future of AI-driven cancer diagnostics.